Course Overview

Print

The Comprehensive Update for Cardiovascular Medicine

Hosted only once every two years, this special program delivers an intensive, comprehensive review of the most important changes in cardiovascular medicine. Cardiologists, internists, vascular specialists, family practitioners, pharmacists, PAs, NPs and other healthcare providers can rely on this program for critical updates and recommendations for incorporating them into your practice.

This program is among the highest rated of Harvard Medical School's CME courses. The education is relevant, practical and can be put to immediate use to ensure your patients receive the highest, most up-to-date quality of care, and achieve the best possible outcomes.

Taught by Harvard Medical School faculty who are distinguished for clinical and teaching excellence, this program is well-suited for cardiovascular medicine specialists as well as generalists and specialists in other fields who care for patients with cardiovascular conditions, including:

  • Atherosclerosis: inflammation and novel risk factors
  • Advanced heart failure
  • Diabetes and its increasing overlap with cardiovascular disease
  • Coronary artery disease
  • Pulmonary embolism and DVT
  • Cardiovascular imaging and stress testing
  • Genetics and its relevance to daily clinical practice
  • Valvular heart disease

The curriculum also focuses on new findings and advances in areas such as:

  • Taming immune and inflammatory responses to treat atherosclerosis
  • Treating and managing advanced heart failure
  • Atrial fibrillation as a systemic cardiovascular illness
  • Integrated multimodality cardiovascular imaging
  • Pulmonary hypertension
  • Late-breaking information regarding cardiovascular benefits and risks of antidiabetic drugs

2019 updates for diagnoses, treatment, and patient care include:

  • State-of-the-art treatments and clinical practices for reducing stroke, heart attack, and cardiovascular death in patients with diabetes
  • A comprehensive approach to managing atrial fibrillation, beyond rate and rhythm control
  • Cardiovascular imaging tests: updates to select, use and act upon the results of CT, magnetic resonance, and nuclear imaging
  • Combination anticoagulation and antiplatelet therapy: new findings that impact the treatment of peripheral arterial disease
  • Guidance to determine whether to use single, dual, or even triple therapy for treatment of coronary artery disease
  • Best practices for the treatment of pulmonary hypertension with combination pharmacological therapy
  • Education to navigate the differing nuances among the five FDA-approved direct oral anticoagulants
  • New strategies to incorporate cardiovascular genetics into daily practice